Privia Health (PRVA) EBIAT (2020 - 2026)

Privia Health has reported EBIAT for 7 years, with the latest figure at $3.7 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT fell 12.09% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $17.6 million (down 3.14% YoY), and the FY2025 full-year result was $22.9 million, up 34.47% from the prior year.
• EBIAT for Q1 2026 stood at $3.7 million, down from $3.8 million in the prior quarter.
• The five-year high for EBIAT was $16.8 million in Q4 2022, with the low at -$18.1 million in Q1 2022.
• Average EBIAT over 5 years is $2.8 million, with a median of $4.0 million recorded in 2024.
• Year-over-year, EBIAT tumbled 422.06% in 2022 and soared 581.96% in 2024.
• Tracing PRVA's EBIAT over 5 years: stood at $16.8 million in 2022, then sank by 95.33% to $787000.0 in 2023, then soared by 581.96% to $5.4 million in 2024, then dropped by 29.61% to $3.8 million in 2025, then declined by 1.8% to $3.7 million in 2026.
• The last three EBIAT figures came in at $3.7 million (Q1 2026), $3.8 million (Q4 2025), and $6.9 million (Q3 2025), per Business Quant data.

Peer Comparison